Vulvar and Vaginal Pain: Causes by Location

Name: Vulvar and Vaginal Pain: Causes by Location, Diagnosis, and Treatment
Creator: Dr. Dina Rezk
Published: 2026-09-03

Burning, stinging or aching “down there” can be hard to describe and even harder to discuss. A normal swab or a clinician saying that the skin “looks normal” may leave you wondering whether anyone believes you. Normal results do not make pain imaginary. They simply change what needs to be considered next.

📚 Articles in This Cluster

The most useful starting point is location: the outer vulva, labia, clitoris, vestibule at the vaginal entrance, inside the vagina, or the perineum between the vaginal opening and anus. Location alone cannot diagnose the cause, but it creates a practical map for examination and testing. This article explains that map, the formal ISSVD classification of vulvar pain, what vulvodynia does—and does not—mean, and how treatment is selected without promising a single cure.

Key takeaways

Not all vulvar pain is vulvodynia. The international consensus first separates pain caused by a specific disorder from vulvodynia, which means vulvar pain lasting at least three months without a clear identifiable cause (ISSVD/ISSWSH/IPPS 2015 terminology).
Vulvodynia can be localized, generalized or mixed; provoked, spontaneous or mixed; primary or secondary; and intermittent, persistent, constant, immediate or delayed (ISSVD/ISSWSH/IPPS 2015 terminology).
A specific disorder and vulvodynia can coexist. Finding a skin condition or previous infection does not automatically explain every part of persistent pain (ISSVD/ISSWSH/IPPS 2015 terminology).
The cotton-swab test maps sensitivity; it does not work as a stand-alone diagnosis. A moistened swab is applied at defined vestibular sites and the response is recorded on a pain map (ACOG Committee Opinion 673).
Treatment is usually individualized and multimodal. Pelvic-floor physiotherapy and psychosocial therapies are common first-line components, while medicines and surgery have more selective roles and uneven evidence (BMJ 10-Minute Consultation on vulvodynia).
A new ulcer, lump, colour change, thickened area, bleeding lesion or new pain after menopause needs examination, not repeated self-treatment (BASHH national guideline on vulval conditions; RCOG Green-top Guideline 41 peer-review draft).

A location-first pain map

Vulvar and vaginal pain can arise from skin, infection, hormonal tissue change, pelvic-floor muscle, nerves, scars, injury, a mass or a persistent pain condition. Pointing to the exact site helps organize these possibilities, but no location or descriptive word is diagnostic on its own.

First, the anatomy in plain language:

The vulva is the external genital area. It includes the outer and inner labia, clitoral area, vestibule and openings of the urethra and vagina.
The vestibule is the sensitive tissue just inside the inner labia around the vaginal and urethral openings.
The vagina is the internal muscular canal.
The perineum is the tissue between the vaginal opening and anus.

Where the pain is felt	Patterns worth reporting	Categories a clinician may consider	What often changes the next step
Whole vulva	Constant or intermittent burning, ache, sensitivity	Dermatosis, hormonal deficiency, infection, generalized vulvodynia, referred or neuropathic pain	Skin findings, swab results, spontaneous vs touch-triggered pattern
One labium or a focal spot	Tender lump, swelling, fissure, ulcer or scar	Cyst/abscess, trauma, dermatosis, infection, focal nerve or scar pain, neoplasia	Visible/palpable lesion, fever, rapid change
Vestibule or vaginal entrance	Pain with light touch, clothing, tampon or insertion	Infection, inflammation, hormonal change, provoked vestibulodynia, pelvic-floor guarding	Cotton-swab map, discharge tests, tissue appearance, muscle findings
Clitoral area	Focal burning, throbbing, touch sensitivity	Dermatosis, adhesion or structural issue, trauma, neuropathic pain, localized vulvodynia	Gentle direct examination; specialist input if unclear
Inside the vagina	Dryness, ache, pressure, discharge, pain with examination	Infection, GSM, scar, pelvic-floor overactivity, prior procedure complication	Speculum only if indicated/tolerated, swabs, pelvic-floor exam
Perineum	Scar tenderness, sit-provoked pain, electric or shooting pain	Obstetric trauma, dermatosis, pelvic-floor pain, pudendal distribution, other nerve injury	Birth/surgery history, scar and neurological assessment

If pain happens specifically with intercourse, the entry-versus-deep triage belongs on Painful Intercourse (Dyspareunia): Causes, Diagnosis, and Treatment. This page stays location-first.

Specific disorder or vulvodynia?

The 2015 ISSVD/ISSWSH/IPPS consensus separates persistent vulvar pain into two branches (ISSVD/ISSWSH/IPPS 2015 terminology):

Vulvar pain caused by a specific disorder, including infectious, inflammatory, neoplastic, neurologic, traumatic, iatrogenic and hormonal causes.
Vulvodynia, defined as vulvar pain lasting at least three months without a clear identifiable cause, although associated factors may be present.

Specific-disorder branch

The consensus examples include:

Infectious: recurrent candidiasis, herpes and other infections.
Inflammatory: lichen sclerosus, lichen planus and other dermatoses.
Neoplastic: Paget disease, squamous cell carcinoma and other lesions.
Neurologic: nerve injury, compression or neuralgia.
Trauma: obstetric injury, other physical trauma and female genital cutting.
Iatrogenic: pain after surgery, chemotherapy or radiation.
Hormonal deficiency: tissue change related to lower oestrogen states.

These categories come from the consensus classification, not a claim that each is equally common (ISSVD/ISSWSH/IPPS 2015 terminology).

Vulvodynia branch

Vulvodynia is not simply “pain that no one understands.” It is a defined clinical diagnosis reached after a careful history, examination and appropriate exclusion of specific disorders. ACOG uses the same three-month/no-clear-cause definition and notes that older terms such as “vulvar vestibulitis” and “vulvar dysesthesia” are no longer used (ACOG Committee Opinion 673).

A person can have both a specific disorder and vulvodynia at the same time (ISSVD/ISSWSH/IPPS 2015 terminology). For example, an infection may resolve, while touch-triggered pain and pelvic-floor guarding continue. That does not prove the infection “caused” vulvodynia, but it explains why clearing one finding may not end the care pathway.

The ISSVD categories of vulvodynia

Only this location-focused page reproduces the patient-facing ISSVD descriptor map.

Classification axis	Categories	What it tells the clinician
Site	Localized (for example vestibulodynia or clitorodynia), generalized, or mixed	Whether pain is confined to one area or extends across the vulva
Provocation	Provoked (insertion or contact), spontaneous, or mixed	Whether touch/activity reliably triggers pain or pain occurs without contact
Onset	Primary or secondary	Whether pain was present from first relevant contact/experience or began after a pain-free period
Temporal pattern	Intermittent, persistent, constant, immediate, or delayed	How pain behaves over time and in relation to a trigger

These descriptors come directly from the consensus terminology (ISSVD/ISSWSH/IPPS 2015 terminology; ACOG Committee Opinion 673). They can be combined. “Localized, provoked, secondary vestibulodynia with immediate pain,” for example, is more informative than “vulvar pain.”

The consensus also lists associated factors involving other pain syndromes, genetics, hormones, inflammation, musculoskeletal function, neurological mechanisms, psychosocial factors and structural differences. These are associations with graded evidence, not established single causes (ISSVD/ISSWSH/IPPS 2015 terminology).

Causes and conditions by location

Generalized vulvar pain

Pain across most or all of the vulva may be spontaneous, contact-triggered or mixed. A clinician first looks for a specific cause: widespread dermatitis, inflammatory dermatosis, infection, hormonal tissue change, medication irritation or a lesion. If pain has lasted at least three months and no clear cause explains it, generalized vulvodynia may be considered.

Generalized pain may coexist with pelvic-floor tenderness or another persistent pain condition. That does not make it “all in the nerves” or “all psychological.” It means the treatment plan may need to address tissue, muscle, nervous-system sensitivity and life impact together.

Vestibular or vaginal-entrance pain

The vestibule is a common site of provoked pain. A cotton swab, tampon, clothing, bicycle saddle or penetration may trigger burning or sharp tenderness. Provoked vestibulodynia is a localized vulvodynia subtype, so the three-month/no-clear-cause requirement still applies (ISSVD/ISSWSH/IPPS 2015 terminology). Tenderness at the entrance for two days during candidiasis is not, by itself, vestibulodynia.

Entry pain also occurs with infection, dermatosis, a fissure, GSM, scar sensitivity and pelvic-floor overactivity. Those alternatives need assessment before a chronic pain label is applied.

Labial pain or a focal lump

A focal tender area prompts inspection and palpation. Swelling, heat, discharge or rapidly increasing pain can suggest infection or abscess. A fissure may come from dermatitis or an inflammatory dermatosis. A persistent thickened, ulcerated, bleeding or colour-changed area needs specialist assessment and sometimes biopsy rather than repeated topical treatment (BASHH national guideline on vulval conditions).

Clitoral pain (clitorodynia)

Clitorodynia is the term for localized vulvodynia at the clitoral area within the ISSVD site classification (ISSVD/ISSWSH/IPPS 2015 terminology). But focal clitoral pain may also have a specific cause, such as a skin disorder, trauma, structural problem or nerve involvement. The examination should be gentle and direct; a general vaginal examination can miss the site entirely.

Internal vaginal pain

Pain felt in the canal may come with dryness, discharge, urinary symptoms, scar sensitivity or an aching pelvic-floor pattern. Infection testing, tissue examination and a consent-based pelvic-floor assessment help separate those categories. GSM can include dryness, burning, irritation, painful intercourse and urinary symptoms associated with oestrogen deficiency (NAMS-published GSM consensus). Full GSM therapy belongs on a dedicated menopause page.

Past prolapse or incontinence surgery changes the history. New pain, exposure, bleeding or discharge after a mesh procedure requires specialist review; this article does not provide a procedure-specific algorithm.

Perineal pain

Perineal pain may follow obstetric tearing, episiotomy or another injury. A scar can be tender, while nearby pelvic-floor muscle or nerve territory can contribute. Pain described as electric or shooting and worse with sitting may prompt neurological assessment, but descriptors alone cannot diagnose a particular nerve disorder; specialist input may be needed.

Pain that started after birth or surgery needs recovery context; see Pain After Childbirth and Gynecological Procedures.

What different sensations can mean

Sensation or pattern	Possible categories to consider	Why it is not diagnostic
Burning	Infection, irritant dermatitis, GSM, vulvodynia, nerve-related pain	Both infectious and non-infectious conditions burn
Itching with soreness	Candidiasis, eczema, lichen sclerosus or other dermatosis	Itch can coexist with pain and needs examination/testing
Electric or shooting	Neuropathic contribution, scar/nerve injury, referred pain	Pain words alone cannot identify which nerve or lesion
Raw or tearing	Fissure, dry tissue, dermatosis, vestibular sensitivity	Microscopic or intermittent changes may be hard to see
Ache or pressure	Pelvic-floor muscle, generalized pain, referred pelvic source	Site and trigger still matter
Pain from light touch	Allodynia, often mapped in vulvodynia assessment	It is a sensory finding, not the final diagnosis
Exaggerated pain from a painful stimulus	Hyperalgesia	It describes response intensity, not cause

Allodynia means pain from a stimulus that normally would not hurt; hyperalgesia is an exaggerated response to a normally painful stimulus (clinical review of female sexual pain). These terms can validate what you feel without pretending to explain why it developed.

“Burning equals thrush” is a particularly risky shortcut. Swabs may be appropriate during symptoms, but repeated antifungal treatment without confirmation can obscure dermatitis or persistent pain. ACOG reports that biopsy found a dermatosis in 61% (55 of 90) of a selected group of refractory patients; this was not a general-population rate, but it shows why reassessment matters (ACOG Committee Opinion 673).

What happens during assessment?

The first visit should feel like a mapping exercise, not an endurance test.

Conversation first

A clinician may ask you to point on a diagram and describe:

exact site or sites;
spontaneous versus provoked pain;
immediate versus delayed pain;
first onset and whether there was ever a pain-free period;
relationship to menstruation, childbirth, surgery, infection, menopause or a medication;
triggers such as touch, sitting, clothing, cycling, urination or washing;
skin, discharge, bladder, bowel or pelvic symptoms;
treatments tried and their effects;
impact on sitting, work, sleep, exercise and intimacy.

For secondary vulvodynia, a 2026 BMJ review advises asking about timing relative to childbirth, surgery, infection or traumatic injury, including sexual assault (BMJ 10-Minute Consultation on vulvodynia). Trauma questions should be sensitive. Draft RCOG guidance recommends universal trauma-informed screening without asking for detailed disclosure and says documentation should be discussed with the patient (RCOG Green-top Guideline 41 peer-review draft).

The ISSVD trauma category explicitly includes obstetric trauma and female genital cutting (ISSVD/ISSWSH/IPPS 2015 terminology). In a Saudi or international clinic, this calls for universal, non-assumptive questions—not profiling by nationality or ethnicity.

Consent-controlled examination

You can ask for a female clinician, a chaperone, an interpreter, explanation before touch, a mirror, a different position, or a conversation-only first visit. Draft RCOG guidance under peer review in 2026 recommends offering choices, allowing patients to pause or decline any part, and treating consent as active and ongoing (RCOG Green-top Guideline 41 peer-review draft). The document is a draft, so its status should be disclosed.

A staged examination may include:

Looking at the vulvar skin without touch.
Inspecting the clitoral area, labia, vestibule and perineum for lesions, inflammation, fissures or scars.
Very light touch to compare sites and map sensitivity.
A cotton-swab map when vestibular pain is relevant.
Pelvic-floor palpation with one finger only if useful and tolerated.
A small speculum only when internal tissue, discharge or the cervix needs assessment and you consent.
Bimanual or neurological examination when the history points beyond the surface.

The 2018 sexual-pain review describes external musculoskeletal assessment, visual/sensory examination, single-digit pelvic-floor palpation, bimanual examination and speculum examination as a sequence, but not every step is required for every patient (clinical review of female sexual pain).

The cotton-swab test

The cotton-swab test uses light touch at defined vulvar or vestibular points to map pain location and sensitivity. It can help distinguish localized from generalized patterns and create a baseline for follow-up, but it cannot by itself prove vulvodynia or identify a cause.

ACOG describes using a moistened cotton swab at defined sites, commonly recorded like clock-face points, grading the response and transferring it to a pain diagram that can be repeated over time (ACOG Committee Opinion 673). Performance varies between clinicians, and the benefit of pelvic-floor physiotherapy in unprovoked vulvodynia is not established, according to the 2026 BMJ review (BMJ 10-Minute Consultation on vulvodynia).

ACOG advises against a 3–5% acetic-acid soak of the vulva during pain evaluation because it is unnecessary and can cause severe pain in patients with vulvodynia (ACOG Committee Opinion 673).

Tests, biopsy and referrals

Tests answer specific questions:

Vaginal/vulvar swab, culture or PCR: when infection is plausible.
Urine testing: when urinary pain or urgency is present.
Biopsy: for a suspicious, changing or unclear lesion—not to “confirm vulvodynia.” No specific histopathology defines vulvodynia (ACOG Committee Opinion 673).
Pelvic-floor assessment: when touch, position, intercourse or internal ache suggests muscle involvement.
Neurological or pain-specialist assessment: for focal sensory change, electric/shooting pain or a suspected neuralgia.
Imaging: selected according to a mass, deep pelvic symptom, surgical history or another clinical finding; routine imaging does not diagnose vulvodynia.

A normal infection test means that tested organisms were not identified under those test conditions. A normal biopsy may exclude some skin disease or neoplasia, but it does not measure pain. Ask, “What has this result ruled out, what remains possible, and what is the next step?” NICE cautions clinicians against invalidating patients when communicating normal or negative tests (NICE chronic pain recommendations).

Treatment decision table

Classification or finding	Purpose	Likely candidates	Limits and risks	Alternatives
Confirmed infection	Clear identified organism and complications	Positive test or supported clinical pathway	Wrong empirical treatment may delay another diagnosis; drug adverse effects	Re-testing, specialist infection care
Dermatosis	Control inflammation, itch, fissuring and tissue damage	Examination/biopsy-supported condition	Needs diagnosis and follow-up; treatment differs by disease	Vulvar dermatologist/gynaecologist referral
GSM/hormonal deficiency	Improve dry, oestrogen-deficient tissue	Selected peri/postmenopausal patients after examination	Grade C evidence for relevant therapies; hormone choices need individual review	Lubricants/moisturisers; dedicated menopause care
Pelvic-floor overactivity	Reduce tenderness and restore relaxation/coordination	Palpation-supported muscle contribution	May flare if too aggressive; unprovoked vulvodynia benefit less certain	Education, graded movement, pain and psychosexual support
Provoked vestibulodynia	Reduce touch sensitivity, guarding and interference	Localized provoked pain ≥3 months after exclusions	Often weeks to months; no single therapy works for everyone	Multimodal PT, CBT, selected topical or surgical options
Generalized/neuropathic pattern	Reduce spontaneous pain and improve function	Persistent spontaneous/generalized pain after assessment	Medication evidence conflicts; adverse effects common	Pain specialist, physiotherapy if indicated, psychological support
Suspicious lesion	Establish diagnosis and treat specific pathology	Ulcer, thickening, colour change, bleeding or unclear lesion	Biopsy discomfort; treatment depends on pathology	Specialist referral; do not delay with empirical creams
Selected refractory localized pain	Remove painful vestibular tissue	Carefully selected provoked vestibulodynia after conservative care	Surgery, recovery, scarring and persistent/new pain	Continue multimodal conservative care; second opinion

Treatments in detail

Treat the specific disorder first

Infection, inflammatory skin disease, a focal lesion, trauma-related pathology and hormonal deficiency each need their own treatment. “Vulvar pain” is not a medication indication by itself. Ask the clinician to name the working diagnosis, what evidence supports it, and when lack of improvement should trigger reassessment.

If a specific disorder improves but pain remains, revisit the map. The consensus allows a specific disorder and vulvodynia to coexist (ISSVD/ISSWSH/IPPS 2015 terminology).

Pelvic-floor physiotherapy

Pelvic-floor physiotherapy can include education, breathing, relaxation, external and internal manual work, movement, biofeedback and a home programme. Current clinical review supports individualized, multimodal care with pelvic-floor physiotherapy and psychosocial treatment as first-line components (BMJ 10-Minute Consultation on vulvodynia).

Purpose: reduce muscle tenderness and protective overactivity, improve movement and restore function. Candidates: patients with pelvic-floor findings or provoked vestibular pain. Limits: availability and expertise vary, and benefit in unprovoked vulvodynia is not established (BMJ 10-Minute Consultation on vulvodynia). Risks: soreness or flare if treatment progresses too quickly. Alternatives: education, CBT/psychosexual support, selected medication or multidisciplinary pain care. Internal techniques always require separate consent.

A 2023 evidence-graded review reported that multimodal physical therapy was more effective than topical lidocaine through six months in one comparative study, with a statistically significant difference; that finding supports physiotherapy but does not guarantee individual response (Vulvodynia: State of the Science).

Psychological and psychosexual therapies

CBT can address pain-related fear, avoidance and communication without implying that pain is imaginary. In reviewed studies, CBT and physical therapy reduced pain and dyspareunia; CBT and vestibulectomy both reduced dyspareunia at 2.5 years, with greater satisfaction after CBT (Vulvodynia: State of the Science).

Topical lidocaine and other topical agents

Topical lidocaine is commonly used for selected patients, sometimes before a predictable trigger. Evidence is not uniformly positive: ACOG cites a double-blind RCT in which 5% lidocaine cream produced a 20% response versus 33% with placebo (ACOG Committee Opinion 673).

Purpose: temporary local pain reduction. Candidates: selected localized or provoked patterns under clinician guidance. Limits: not a cure; weak or negative trial signal. Risks: burning, irritation, numbness and partner exposure. Alternatives: physiotherapy, behavioural therapy or reassessment of the diagnosis.

Oral medicines for neuropathic pain

Medicines used for other neuropathic pain conditions are sometimes considered for generalized or spontaneous vulvodynia. Evidence is conflicting. A 2026 BMJ review reports that a recent meta-analysis did not confirm benefit for amitriptyline and places oral neuropathic agents after first-line approaches (BMJ 10-Minute Consultation on vulvodynia).

Purpose: reduce neuropathic-type pain and improve function. Candidates: selected persistent spontaneous/generalized patterns after exclusions. Limits: response is unpredictable and may take time. Risks: medicine-specific effects such as sedation, dizziness, dry mouth or mood effects. Alternatives: multidisciplinary pain care, therapy, sleep and activity support, or a different class after review. This article deliberately gives no doses.

Injections and botulinum toxin

Invasive pharmacological options have been studied, including botulinum toxin. The evidence-graded review placed botulinum toxin type A at a relatively high evidence level among invasive options, but the wider treatment literature still includes small trials and case series (Vulvodynia: State of the Science).

Purpose: target selected muscle or pain mechanisms. Candidates: specialist-selected patients after conservative care. Limits: protocol and durability are uncertain. Risks: procedure pain, temporary weakness, infection, cost and no response. Alternatives: physiotherapy, CBT, topical or oral treatment, and a second opinion. It is not routine first-line care.

Vestibulectomy

Vestibulectomy removes selected painful vestibular tissue. ACOG reports published success ranges of 60–90% compared with 40–80% for non-surgical treatments, but these broad ranges come from heterogeneous evidence and surgery is reserved for selected patients (ACOG Committee Opinion 673).

Purpose: treat refractory, localized provoked vestibular pain. Candidates: carefully selected patients with a stable diagnosis after adequate conservative care. Limits: does not address generalized, spontaneous or centrally maintained pain. Risks: anaesthetic and surgical complications, bleeding, infection, scarring, altered sensation, persistent pain or new pain. Alternatives: continued multimodal treatment, specialist review or CBT, which showed comparable dyspareunia reduction and greater satisfaction in one long-term comparison (Vulvodynia: State of the Science).

GSM treatment stays concise here

GSM may be managed with lubricants, moisturisers and, for selected patients, local hormonal or other prescription therapy. The 2025 AUA/SUFU/AUGS guideline grades the relevant recommendations at Evidence Level C, even where recommendation strength differs (AUA/SUFU/AUGS GSM Guideline 2025). Breast-cancer history and postmenopausal bleeding require individualized assessment. A dedicated GSM article should cover those choices fully.

No energy-device marketing

Laser, radiofrequency and other energy-based vaginal devices should not be marketed as treatments for vulvar or vaginal pain. The evidence supplied for this article does not establish a safe, effective pain-treatment role, so these devices are not included in the treatment pathway.

Self-care and flare reduction

Vulvar care aims to remove avoidable irritation without turning daily life into a long list of restrictions.

ACOG advises cotton underwear, avoiding soap and vulvar cleansers on the vulva, avoiding perfumed products and douching, using preservative-free emollients, patting rather than rubbing dry, and using adequate lubrication for intercourse (ACOG Committee Opinion 673). You do not need to follow every measure forever; use the least restrictive plan that reduces symptoms.

Practical steps:

Wash the vulva gently with water; avoid internal washing.
Stop scented wipes, deodorants, harsh cleansers and repeated “hygiene” treatments.
Change out of sweaty clothing and use breathable fabric when practical in Riyadh’s heat.
During a flare, reduce pressure from tight clothing, cycling or prolonged sitting if those are your triggers.
Use a cool pack wrapped in cloth for short periods if it feels soothing; do not place ice directly on skin.
Track exact location, trigger and duration rather than only a global pain score.
Follow prescribed topical directions; more frequent application can increase irritation.
Avoid strengthening exercises until pelvic-floor tone has been assessed.

This Riyadh climate layer is a practical adaptation of guideline-supported vulvar-care measures, not evidence that heat causes vulvodynia. If a product is labelled only in Arabic and you do not read Arabic comfortably, ask a pharmacist to confirm ingredients and intended site before use.

🚨 Red flags

Seek urgent or same-day care

Fever with rapidly increasing vulvar pain, redness, swelling or discharge may signal infection or abscess.
Inability to pass urine needs urgent assessment.
Severe, rapidly escalating pain or swelling that prevents normal function should not wait for a routine appointment.
Sudden pelvic pain with collapse, shoulder-tip pain, fever or rigors requires emergency assessment (NHS Scotland acute pelvic pain guideline).

Arrange prompt examination

Any persistent ulcer, lump, colour change, thickening, bleeding lesion or lesion that is difficult to identify should be examined and may need biopsy (BASHH national guideline on vulval conditions; ACOG Committee Opinion 673).
New vulvar or pelvic pain after menopause is a red flag in the 2026 RCOG peer-review draft (RCOG Green-top Guideline 41 peer-review draft).
Repeated treatment for presumed thrush that does not work should trigger examination, testing and reconsideration of the diagnosis.

The ISSVD specific-disorder branch includes neoplastic causes such as Paget disease and squamous cell carcinoma, which is why persistent lesions must be assessed before pain is labelled vulvodynia (ISSVD/ISSWSH/IPPS 2015 terminology). Most vulvar pain is not cancer, but visual change changes the urgency.

Myths and facts

Myth: All vulvar pain is vulvodynia.
Fact: Vulvodynia requires at least three months of pain without a clear cause; infection, inflammatory disease, lesions, neurological injury, trauma and hormonal deficiency sit in a separate specific-disorder branch (ISSVD/ISSWSH/IPPS 2015 terminology).

Myth: Normal swabs mean the pain is psychological.
Fact: Swabs answer infection questions. They do not measure pelvic-floor tenderness, nerve sensitivity or vulvodynia.

Myth: Burning always means thrush.
Fact: Infection, irritant dermatitis, GSM, vulvodynia and neuropathic pain can all burn. Testing and examination separate them.

Myth: A biopsy confirms vulvodynia.
Fact: No specific histopathology defines vulvodynia; biopsy is used to evaluate suspicious or unclear lesions (ACOG Committee Opinion 673).

Myth: The cotton-swab test has to be extremely painful to be useful.
Fact: It maps the response to light touch. It can be slowed, modified or stopped.

Myth: Kegel exercises help every pelvic pain condition.
Fact: If muscles are already overactive or tender, strengthening may be poorly matched. Assessment should come first.

Myth: Lidocaine is a proven cure.
Fact: In one double-blind RCT cited by ACOG, response was 20% with 5% lidocaine cream and 33% with placebo (ACOG Committee Opinion 673).

Myth: Surgery is the final answer when nothing else works.
Fact: Vestibulectomy is reserved for selected refractory localized provoked pain, and conservative therapies may achieve comparable dyspareunia improvement with higher satisfaction in some evidence (Vulvodynia: State of the Science).

Myth: Pain treatment should eliminate every symptom quickly.
Fact: ACOG advises that improvement may take weeks to months and complete elimination may not be possible (ACOG Committee Opinion 673). A good plan also tracks sitting, sleep, work, movement and intimacy.

Myth: Normal swabs mean the pain is psychological.
Fact: Swabs answer infection questions. They do not measure pelvic-floor tenderness, nerve sensitivity or vulvodynia.

Myth: Burning always means thrush.
Fact: Infection, irritant dermatitis, GSM, vulvodynia and neuropathic pain can all burn. Testing and examination separate them.

Myth: A biopsy confirms vulvodynia.
Fact: No specific histopathology defines vulvodynia; biopsy is used to evaluate suspicious or unclear lesions (ACOG Committee Opinion 673).

Myth: The cotton-swab test has to be extremely painful to be useful.
Fact: It maps the response to light touch. It can be slowed, modified or stopped.

Myth: Kegel exercises help every pelvic pain condition.
Fact: If muscles are already overactive or tender, strengthening may be poorly matched. Assessment should come first.

Myth: Lidocaine is a proven cure.
Fact: In one double-blind RCT cited by ACOG, response was 20% with 5% lidocaine cream and 33% with placebo (ACOG Committee Opinion 673).

Frequently asked questions

What is vulvodynia?

Vulvodynia is vulvar pain lasting at least three months without a clear identifiable cause after appropriate assessment (ISSVD/ISSWSH/IPPS 2015 terminology). It may be localized or generalized, provoked or spontaneous, and those categories can be mixed.

What is the difference between vulvodynia and vestibulodynia?

Vulvodynia is the broader diagnosis. Vestibulodynia is localized vulvodynia at the vestibule; it may be provoked, spontaneous or mixed, although provoked pain is a common clinical pattern (ISSVD/ISSWSH/IPPS 2015 terminology).

Can a person have a skin condition and vulvodynia together?

Yes. The consensus explicitly says a specific disorder and vulvodynia can coexist (ISSVD/ISSWSH/IPPS 2015 terminology). Treating the skin condition remains necessary even if a persistent pain plan is also needed.

What is the cotton-swab test, and can I stop it?

A clinician lightly touches defined sites with a moistened cotton swab and records where pain occurs (ACOG Committee Opinion 673). You can ask to start away from the painful area, pause or stop at any time.

Does vulvodynia show on a swab or biopsy?

No infection swab or biopsy confirms vulvodynia. Swabs help exclude infection, while biopsy is used for suspicious or unclear lesions because vulvodynia has no defining histopathology (ACOG Committee Opinion 673).

Can pelvic-floor tightness happen with vulvar pain?

Yes. Pelvic-floor overactivity should be assessed as part of evaluation, especially when pain is positional or intermittent (BMJ 10-Minute Consultation on vulvodynia). It may be one contributor rather than the entire diagnosis.

Is clitoral pain a recognized condition?

Yes. Clitorodynia appears as a localized site category in the ISSVD classification (ISSVD/ISSWSH/IPPS 2015 terminology). A clinician still needs to look for a specific skin, structural, traumatic or neurological cause before applying a vulvodynia label.

How long does treatment take?

Improvement often takes weeks to months, and complete pain elimination is not possible for everyone (ACOG Committee Opinion 673). The timeline depends on classification, duration, coexisting muscle or skin findings, access to therapy and personal goals.

The bottom line

The safest way to make sense of vulvar and vaginal pain is to locate it, describe what provokes it, examine for a specific disorder, and only then apply a persistent-pain classification. Vulvodynia is real, but it is not a synonym for every vulvar symptom. The definition requires at least three months of pain without a clear identifiable cause. For pain that is not mainly vulvar or vaginal, use the vaginal and pelvic pain hub to choose another route.

A normal swab can be useful information. So can a normal-looking examination. Neither proves that nothing is wrong. The next step may be a more precise vestibular map, pelvic-floor assessment, skin specialist review or multidisciplinary pain plan. No treatment can be guaranteed.

To request a private assessment in Riyadh, contact Dr. Dina Rezk Clinic through its booking channel. You may ask before the visit for a female clinician, chaperone, interpreter or conversation-only first appointment. For privacy, do not send intimate photographs or a detailed history through an unsecured account; ask which secure channel the clinic uses for clinical information.

Vulvar and Vaginal Pain: Causes by Location, Diagnosis, and Treatment